A carregar...

Toxicities associated with PD-1/PD-L1 blockade

Immune checkpoint inhibitors, particularly those targeting PD-1/PD-L1, produce durable responses in a subset of patients across cancer types. Although often well-tolerated, these agents can induce a broad spectrum of autoimmune-like complications that may affect any organ system. Treatment of these...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer J
Main Authors: Wang, Daniel Y., Johnson, Douglas B., Davis, Elizabeth J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5784852/
https://ncbi.nlm.nih.gov/pubmed/29360726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000296
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!